Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
Lecture 4 Vancomycin resistance VRE VISA / hVISA / VRSA Thursday – 1/17/ ppt download
Detection of Staphylococcus aureus with reduced susceptibility to vancomycin in a South African teaching hospital
14th March 2013 Susceptibility testing for Vancomycin in S. aureus : What do we do now? Robin A Howe Antimicrobial use in Primary Care. - ppt download
Frontiers | Rapid Detection of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Based on Matrix-Assisted Laser Desorption Ionization Time-of-Flight: Using a Machine Learning Approach and Unbiased Validation
Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
The First Vancomycin-Intermediate Staphylococcus aureus Strains Isolated from Patients in Thailand | Journal of Clinical Microbiology
Daptomycin and vancomycin heteroresistance revealed among CC5-SCCmecII MRSA clone and in vitro evaluation of treatment alternatives – CIBFar
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
PAPs of three VISA isolates, one hetero-VISA isolate, and control... | Download Scientific Diagram
Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
Frontiers | IS256-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a Staphylococcus aureus Clinical Isolate
Ceftaroline fosamil: drug profile and clinical data
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
![PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/306a583084d23ac2766f122cd384bf9952effebb/4-Figure2-1.png "PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar")
PDF] Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. | Semantic Scholar
Association between cell growth and vancomycin resistance in clinical community-associated methicillin-resistant Staphylococcus aureus - Document - Gale Academic OneFile
Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections | Annals of Clinical Microbiology and Antimicrobials | Full Text
Population analysis profile of VISA, hetero-VISA, and VSMRSA.... | Download Scientific Diagram
PDF) VISA, hetero-VISA and VRSA: the end of the vancomycin era?
xmlinkhub
Aislamiento de Staphylococcus aureus hetero-resistente a vancomicina en Hospital Clínico Regional de Concepción, Chile
Le cauchemar des bactéries multirésistantes
Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
Acknowledgements References Genetic analysis of 17 genes in Staphylococcus aureus with reduced susceptibility to vancomycin (VIS
Synergy of Arbekacin-based Combinations Against Vancomycin Hetero-intermediate Staphylococcus aureus
